Prostate cancer Board decisions

The Board has remanded the case due to inconsistencies in personnel records and a need for additional development regarding the Veteran's service in Vietnam. Both prostate cancer and erectile dysfunction claims are now pending.

The Veteran's heart disability, prostate cancer, diabetes, bilateral upper and lower extremity neuropathy, bilateral hearing loss, and tinnitus are not service-connected due to lack of evidence showing they were incurred or aggravated by his military service.,Specifically, the Board found insufficient evidence to support a finding that the Veteran was exposed to herbicide agents during his time in Thailand. The Veteran's service records do not indicate he had any ongoing problems with these conditions while in service and there is no other competent medical evidence suggesting an association to service.

The Board has denied service connection for chest pain, right ankle disability, bilateral wrist disabilities, prostate cancer, and penis and groin area pain. The claims are remanded for further development.

The Veteran's application for reimbursement of beneficiary travel expenses from August 22, 2018, through September 19, 2018 was timely submitted and the appeal is granted.

The Board has granted service connection for prostate cancer on a presumptive basis due to exposure to Agent Orange during active duty in Korea. The claim for erectile dysfunction secondary to prostate cancer is remanded for further evaluation.

The Veteran's claims for service connection for a heart disorder and prostate disease due to exposure to herbicides have been denied.,There is no current diagnosis of ischemic heart disease or prostate cancer, thus denying presumptive service connection.

The Board has remanded the cases for further development due to incomplete VA treatment records from private urologists.

The Board has remanded the case due to inadequate medical opinions regarding the Veteran's prostate cancer and its relation to service, including asbestos exposure. The Veteran is requested to provide additional records and an addendum opinion from an oncologist.

The Board has granted service connection for prostate cancer and diabetes mellitus, type II, as these conditions are presumed to be related to the Veteran's in-service exposure to herbicide agents.

The Board has dismissed all claims of service connection due to a request for withdrawal by the Veteran's representative.

The Veteran's claims for service connection for prostate cancer, erectile dysfunction as secondary to prostate cancer, and urinary incontinence as secondary to prostate cancer have all been denied. The Board found that the evidence did not support a finding of herbicide exposure on a facts-found or direct basis during active service.

The Board has granted service connection for gastroesophageal reflux disease (GERD) with duodenal bulb scarring, but denied service connection for basal cell carcinoma, bladder cancer, non-Hodgkin's lymphoma, and prostate cancer due to lack of evidence linking these conditions to in-service exposure or service.

The Veteran's prostate cancer residuals have been rated at a noncompensable level prior to July 22, 2019. From July 22, 2019 to May 23, 2021, the Veteran is granted a 10 percent rating for urinary frequency resulting in awakening from sleep two times per night.

The Board denied service connection for prostate cancer as there was no evidence of exposure to contaminants that could have caused the condition, and the Veteran's claim is not supported by the weight of the medical evidence.

The Veteran's prostate cancer was previously rated at 100% but the rating has been reduced to 20%. The appeal is for an increased rating of residuals of prostate cancer, which remains denied.

The Board denied service connection for prostate cancer and throat cancer, finding no evidence of herbicide exposure in service or a direct link to service.

The Board has denied service connection for prostate cancer, finding that the Veteran's prostate cancer was not caused by his active duty service. The Board has also remanded the issue of service connection for ankylosing spondylitis.,Service connection will be determined based on whether there is a link between the current disability and the in-service disease or injury.

The Board has determined that the Veteran's prostate cancer is not related to service, including his exposure to petroleum-related chemicals as a petroleum supply specialist. The claim for service connection is denied.

The Veteran's tinnitus is granted service connection. The Board has remanded the claims for restless leg syndrome, low back disability, Morton's neuroma of the left foot, prostate cancer, lung disability, and dental disability due to lack of nexus opinions.

The Board denied service connection for prostate cancer, heart disease (claimed as atrial fibrillation and ischemic heart disease), and erectile dysfunction. The Veteran was not shown to have had exposure to herbicide agents during his military service.